ORASURE TECHNOLOGIES INC
OSURNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $115.0M | $185.8M | $405.5M | $387.5M | $233.7M | $171.7M |
| Operating income | −$72.0M | −$28.3M | $32.7M | −$22.2M | −$10.2M | −$5.2M |
| Net income | −$68.7M | −$19.5M | $53.7M | −$17.1M | −$23.0M | −$14.9M |
| Total assets | $403.2M | $479.7M | $482.8M | $444.2M | $461.0M | $454.5M |
| Total liabilities | $62.3M | $69.3M | $52.2M | $79.8M | $80.5M | $55.9M |
| Equity | $340.8M | $410.3M | $430.7M | $364.4M | $380.5M | $398.6M |
| EPS (diluted) | $-0.94 | $-0.26 | $0.72 | $-0.24 | $-0.32 | $-0.22 |
| Shares out. | 74.8M | 73.8M | 73.2M | 72.3M | 71.9M | 62.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −62.6%
- Net margin
- −59.8%
- Return on equity
- −20.2%
- Return on assets
- −17.0%
- Return on capital (ROCE)
- −19.8%
- Liabilities / assets
- 15.5%
- Debt / equity
- 0.18×
- Book value / share
- $4.56
- Revenue growth (YoY)
- −38.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 6.76safe
- Accruals / assets
- −4.9%clean
- Beneish M-Score
- -2.64normal
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 warning● 3 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.1M | 3.8 | +1.8% |
| Apr 30, 2026 | 3.0M | 8.5 | -6.7% |
| Apr 15, 2026 | 3.2M | 10.0 | -5.9% |
| Mar 31, 2026 | 3.4M | 5.6 | -2.6% |
| Mar 13, 2026 | 3.5M | 7.0 | -7.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosureMay 6, 2026
- Entered a material agreement · Director / officer change · Regulation FD disclosureApr 17, 2026
- Regulation FD disclosureMar 30, 2026
- Director / officer changeMar 5, 2026
- Results of operations · Regulation FD disclosureFeb 25, 2026
- Regulation FD disclosure · Other material eventJan 5, 2026
- Other material eventDec 1, 2025
- Results of operations · Regulation FD disclosureNov 5, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 14, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 14, 2026
- 3INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIESMay 14, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 14, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 14, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMay 14, 2026
- 10-QMay 8, 2026
- 8-KMay 6, 2026
- ARSApr 30, 2026
- DEF 14AApr 30, 2026
- SCHEDULE 13GApr 30, 2026
- PRE 14AApr 20, 2026
- SCHEDULE 13D/AApr 20, 2026
- DEFA14AApr 17, 2026
- DEFA14AApr 17, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.